Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

New vaccine technologies.

¹Quality Assurance and Safety of Biologicals, Vaccines and Biologicals, Health Technology and Pharmaceuticals, World Health Organisation, Geneva, Switzerland. woodd@who.int

Developments in Biologicals

|April 8, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Micro-computed Tomography Analysis of Marginal and Internal Fit of Endocrowns Fabricated from Three CAD/CAM Materials.

Operative dentistry·2022

Same author

Increased Handpiece Speeds without Air Coolant: Aerosols and Thermal Impact.

Journal of dental research·2022

Same author

Dental Mitigation Strategies to Reduce Aerosolization of SARS-CoV-2.

Journal of dental research·2021

Same author

The Effects of Colored Pigments on the Translucency of Experimental Dental Resin Composites.

The European journal of prosthodontics and restorative dentistry·2019

Same author

Wound Discharge After Pharmacological Thromboprophylaxis in Lower Limb Arthroplasty.

The Journal of arthroplasty·2017

Same author

An 18-year retrospective study on the outcomes of keratoacanthomas with different treatment modalities at a single academic centre.

The British journal of dermatology·2016

Same journal

Review of Ebola virus infections in domestic animals.

Developments in biologicals·2013

Same journal

Ebola: facing a new transboundary animal disease?

Developments in biologicals·2013

Same journal

Opportunities in diagnostic and vaccine approaches to mitigate potential heartwater spreading and impact on the American mainland.

Developments in biologicals·2013

Same journal

Q fever diagnosis and control in domestic ruminants.

Developments in biologicals·2013

Same journal

Schmallenberg virus.

Developments in biologicals·2013

Same journal

Classical swine fever.

Developments in biologicals·2013

See all related articles

New vaccine development is rapidly advancing with novel technologies and approaches. Pre-clinical evaluations, often using animal models, are crucial for assessing safety and efficacy before human trials and regulatory approval.

Area of Science:

Vaccinology
Immunology
Pre-clinical research

Background:

Vaccine development is experiencing significant growth, driven by advances in genomics and proteomics.
Exploration of novel vaccine approaches includes DNA vaccines, combination vaccines, new formulations, delivery routes, and adjuvants.
Emerging needs, such as defense vaccines, are also being identified.

Purpose of the Study:

To highlight the critical role of pre-clinical evaluation in the vaccine development pipeline.
To discuss the challenges and importance of animal models in assessing vaccine safety and efficacy.
To underscore the regulatory considerations for new vaccine applications.

Main Methods:

Pre-clinical evaluation of candidate vaccines.

Related Experiment Videos

Laboratory assessments during clinical development.

Utilizing animal models for safety and efficacy studies.

Regulatory review processes, including risk-benefit analysis.

Main Results:

Pre-clinical and laboratory data are essential for marketing authorization applications.
Regulatory authorities rely on precedent and risk-benefit analyses for novel products.
New vaccine technologies present unique challenges for safety and efficacy evaluation.

Conclusions:

Pre-clinical evaluation is a mandatory step for all new vaccine candidates before human trials.
Animal models play a vital role in supporting vaccine development and regulatory submissions.
The increasing number of new vaccine candidates necessitates robust evaluation frameworks.